The New York Times
WASHINGTON — A global shortage of a radioactive drug crucial to tests for cardiac disease, cancer
and kidney function in children is emerging because two aging nuclear
reactors that provide most of the world’s supply are shut for repairs.
The 51-year-old reactor in Ontario, Canada,
that produces most of this drug, a radioisotope, has been shut since
May 14 because of safety problems, and it will stay shut through the
end of the year, at least... Read More
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
